Published in
Springer, Cancer Chemotherapy and Pharmacology, 5(87), p. 599-611, 2021
DOI: 10.1007/s00280-020-04229-3
Links
Tools
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies
Journal article published in 2021 by
Katharine A. Collier 
,
Hugo Valencia,
Herbert Newton ,
Erinn M. Hade ,
Douglas W. Sborov ,
Robert Cavaliere,
Ming Poi ,
Mitch A. Phelps ,
Sophia G. Liva ,
Christopher C. Coss ,
Jiang Wang,
Soun Khountham,
Paul Monk ,
Charles L. Shapiro,
Richard Piekarz
and other authors.
,
Hugo Valencia,
Herbert Newton ,
Erinn M. Hade ,
Douglas W. Sborov ,
Robert Cavaliere,
Ming Poi ,
Mitch A. Phelps ,
Sophia G. Liva ,
Christopher C. Coss ,
Jiang Wang,
Soun Khountham,
Paul Monk ,
Charles L. Shapiro,
Richard Piekarz
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 